Synthesis and anticancer activity of 3′-[4-fluoroaryl-(1,2,3-triazol-1-yl)]-3′-deoxythymidine analogs and their phosphoramidates

Abstract

A series of novel 4-chlorophenyl N-alkyl phosphoramidates of 3′-[4-fluoroaryl-(1,2,3-triazol-1-yl)]-3′-deoxythymidines (20–49) was synthesized by means of phosphorylation of 3′-[4-aryl-(1,2,3-triazol-1-yl)]-3′-deoxythymidines (7–11) with 4-chlorophenyl phosphoroditriazolide (14), followed by a reaction with the appropriate amine. The synthesized compounds 7–11 and 20–49 were evaluated along with four known anticancer compounds for their cytotoxic activity in human cancer cell lines: cervical (HeLa), nasopharyngeal (KB), breast (MCF-7), osteosarcoma (143B) (only selected compounds 20, 24, 28, 32–36, 38, 40, 46) and normal human dermal fibroblast cell line (HDF) using the sulforhodamine B (SRB) assay. Among 3′-[4-aryl-(1,2,3-triazol-1-yl)]-3′-deoxythymidines (7–11) the highest activity in all the investigated cancer cells was displayed by 3′-[4-(3-fluorophenyl)-(1,2,3-triazol-1-yl)]-3′-deoxythymidine (9) (IC₅₀ in the range of 2.58–3.61?μM) and its activity was higher than that of cytarabine. Among phosphoramidates 20–49 the highest activity was demonstrated by N-n-propyl phosphoramidate of 3′-[4-(3-fluorophenyl)-(1,2,3-triazol-1-yl)]-3′-deoxythymidine (35) in all the cancer cells (IC₅₀ in the range of 0.97–1.94?μM). Also N-ethyl phosphoramidate of 3′-[4-(3-fluorophenyl)-(1,2,3-triazol-1-yl)]-3′-deoxythymidine (33) exhibited good activity in all the used cell lines (IC₅₀ in the range of 4.79–4.96?μM).     

Synthesis, pharmacological activity and structure affinity relationships of spirocyclic σ(1) receptor ligands with a (2-fluoroethyl) residue in 3-position

In order to develop a fluorinated radiotracer for imaging of ??₁ receptors in the central nervous system a series of (2-fluoroethyl) substituted spirocyclic piperidines 3 has been prepared. In the key step of the synthesis 2-bromocinnamaldehyde acetal 5 was added to piperidones 6 with various substituents at the N-atom. Unexpectedly, this reaction led to 2-benzoxepines 8, which were contracted with acid to afford the spirocyclic 2-benzofuranacetaldehydes 9. The best yields were obtained, when the transformations up to the alcohols 10 were performed without isolation of intermediates. Generally the (2-fluoroethyl) derivatives 3 have higher ??₁ affinity and ??₁/??₂ selectivity than the corresponding (3-fluoropropyl) derivatives 2. The most promising candidate for the development as radiotracer is the (2-fluoroethyl) derivative 3a (WMS-1828, fluspidine, 1′-benzyl-3-(2-fluoroethyl)-3H-spiro[[2]benzofuran-1,4′-piperidine]), which shows subnanomolar ??₁ affinity (K_i = 0.59 nM) and excellent selectivity over the ??₂ subtype (1331-fold) as well as some other receptor systems. The novel synthetic strategy also allows the systematic pharmacological evaluation of intermediate alcohols 10. Despite their high ??₁ affinity (K_i = 6-32 nM) and selectivity the alcohols 10 are 10-30-fold less potent than the bioisosteric fluoro derivatives 3.     

Synthesis and structure of a novel molybdenum-iron-sulfur cluster with Mo2Fe2 core and all-disulfide chelate ligands, [Mo2Fe2(μ3-S)4(S2CNEt2)5] CH3CN

The cluster compound [Mo₂Fe₂(μ₃-S)₄- (S₂CNEt₂)₅]CH₃CN has been prepared from the reaction system containing (NH₄)₂MoS₄, FeCl₃, NaS₂CNEt₂, PhSH and NaOCH₃. The crystal and molecular structure have been determined by the low temperature X-ray diffraction technique. The compound crystallizes in space group P2₁/c of the monoclinic system with a = 19.397(7), b = 10.891(7), c = 24.302(8) Å, β = 108.95(2)° and Z = 4. With use of 2647 reflections (I)>2.5σ(I)) the structure was refined to R(R_w) = 0.045(0.036). The cluster Mo₂Fe₂S₄(S₂CNEt₂)₅ has a cubane-like skeleton [Mo₂Fe₂S₄]⁵⁺. Each metal atom is coordinated by three μ₃-S atoms and a disulfide chelate terminal ligand. The fifth S₂CNEt₂ group as a bridging ligand coordinates to two Mo atoms. In a molecule of the compound, the two Mo atoms are equivalent but the two Fe atoms are unequivalent.     

Anionopentaaminecobalt(III) complexes with polyamine ligands. 25. The resolution and base hydrolysis kinetics of mer-[CoCl(en)(NH2CH2CH  NCH2CH2NH2)]ZnCl4, a complex with an unsymmetrical triamine ligand

Racemic mer-[CoCl(en)(NH₂CH₂CHNCH₂CH₂NH₂)]ZnCl₄, which contains no dissymetric chelate rings, no asymmetric carbon centers and no asymmetric nitrogen centers, has been resolved using sodium arsenic(III)—(+)-tartrate. The chirality arises by virtue of the coordinated unsymmetric tridentate ligand and the less soluble diastereoisomeride is associated with the (+)-cation. The rate of base hydrolysis was measured spectrophotometrically using tris buffers. Kinetic parameters (25 °C, \3m; ∼ 0.04 M) are k_OH = 1.28 X 10³ M⁻³ s⁻¹, E_a = 87.0 ± 0.7 kJ mol⁻¹ and ΔS^#; = +98 ± 1.4 J K⁻¹ mol⁻¹. Complete racemisation accompanies the base hydrolysis reaction and the rate of loss of optical activity is 0.5 times that of base hydrolysis. These data are interpreted in terms of the formation of a symmetrical trigonal bipyramid intermediate generated from the conjugate base.     

Reactivity of [PdCl(μ-med)]2 with monodentate or bidentate ligands. Structure of the dinuclear complexes [Pd(μ-med)(PPh3)]2(BF4)2 and [Pd(μ-med)(bpy)]2(BF4)2. [Hmed=N-(2-mercaptoethyl)-3,5-dimethylpyrazole]

Treatment of the ligand N-(2-mercaptoethyl)-3,5-dimethylpyrazole with [Pd(CH₃COO)₂]₃ and reaction of [PdCl(μ-med)]₂ with pyridine (py) or triphenylphosphine (PPh₃) in the presence of AgBF₄ produced the following complexes: [Pd(CH₃COO)(μ-med)]₂, [Pd(μ-med)(py)]₂(BF₄)₂ and [Pd(μ-med)(PPh₃)]₂(BF₄)₂. Similar reactions carried out with 2,2^′-bipyridine (bpy) or 1,3-bis(diphenylphosphino)propane (dppp) produced [Pd(μ-med)(bpy)]_x(BF₄)_x (x=1 or 2) and [Pd(μ-med)(dppp)]_x(BF₄)_x (x=1 or 2). Treatment of [Pd(μ-med)(bpy)]_x(BF₄)_x with [PdCl₂(CH₃CN)₂] produced [Pd₃Cl₂(μ-med)₂(bpy)₂](BF₄)₂. Treatment of [Pd(μ-med)(dppp)]_x(BF₄)_x with [PdCl₂(CH₃CN)₂] produced a mixture of [Pd(μ-Cl)(dppp)]₂(BF₄)₂ and [Pd(μ-med)₂(dppp)]²⁺. X-ray crystal structures of [Pd(μ-med)(PPh₃)]₂(BF₄)₂ · 2CH₃CN and [Pd(μ-med)(bpy)]₂(BF₄)₂ · 0.5CH₃OH are presented.     

Design and synthesis of a novel series of (1′S,2R,4′S)-3H-4′-azaspiro[benzo[4,5]imidazo[2,1-b]oxazole-2,2′-bicyclo[2.2.2]octanes] with high affinity for the α7 neuronal nicotinic receptor

We describe an efficient and convergent synthesis of a series of (1′S,2R,4′S)-3H-4′-azaspiro[benzo[4,5]imidazo[2,1-b]oxazole-2,2′-bicyclo[2.2.2]octanes] displaying potency for the α7 nicotinic acetylcholine receptor (nAChR) and good selectivity vs. the related 5-HT_3A receptor.     

Oxidation of [Ir(η-C5Me5)(C3S5)] [C3S5 = 4,5-disulfanyl-1,3-dithiole-2-thionate(2−)] and X-ray crystal structure of [IrBr(η-C5Me5)(μ-C2S4)IrBr(η-C5Me5)]

[Ir(η⁵-C₅Me₅)(C₃S₅)] [C₃S₅²⁻ = 4,5-disulfanyl-1,3-dithiole-2-thionate(2−)] was prepared by a reaction of [NMe₄]₂[C₃S₅] with [Ir(η⁵- C₅Me₅)Cl₂]₂ in ethanol. It was reacted with bromine to afford a paramagnetic species [IrBr(η⁵-C₅Me₅)(C₃S₅)] with the Ir-Br bond and in the one-electron-oxidized state, and a diamagnetic dinuclear species [IrBr(η⁵-C₅Me₅)(μ-C₂S₄)IrBr(η⁵-C₅Me₅)]. ESR spectra for the one-electron-oxidized species in solution are discussed. The X-ray crystal structural analysis for the latter complex revealed the geometry consisting of dinuclear IrBr(η⁵-C₅Me₅) moieties bridged by the C₂S₄²⁻ ligand.     

Design of new potent and selective secretory phospholipase A2 inhibitors. 6-Synthesis,structure–activity relationships and molecular modelling of 1-substituted-4-[4,5-dihydro-1,2,4-(4H)-oxadiazol-5-one-3-yl(methyl)]-functionalized aryl piperazin/one/dione derivatives

The group IIA human non-pancreatic secretory phospholipase A₂ (hnp-sPLA₂) is one of the enzymes implied in the inflammatory process. In the course of our work on inhibitors of this enzyme we investigated the influence of rigidity of the piperazine region on the biological activity. Several modifications were explored. Various linkers, such as amide, urea, carbamate, or alkoxyphenyl were inserted between the piperazine and the lipophilic chain. Also, modification of the piperazine core to incorporate carbonyl groups was studied. In an in vitro fluorimetric assay using the human GIIA (HPLA₂) and porcine pancreatic GIB enzymes, compound 60a (Y = phenoxy, R = C₁₈H₃₇, Z = CH₂) had the optimal activity with an IC₅₀ = 30 nM on HPLA₂. By means of molecular modelling we attempted to get informations towards comprehension of differences in activity.     

[Cu4(H2O)4(dmapox)2(btc)]n · 10nH2O: The first two-dimensional polymeric copper(II) complex with bridging μ-trans-oxamidate and μ4-1,2,4,5-benzentetracarboxylato ligands: Synthesis, crystal structure and DNA binding studies

A two-dimensional copper(II) polymer with formula of [Cu₄(H₂O)₄(dmapox)₂(btc)]_n · 10nH₂O, where dmapox is the dianion of N,N′-bis[3-(dimethylamino)propyl]oxamide and btc is the tetra-anion of 1,2,4,5-benzenetetracarboxylic acid, was synthesized and characterized by elemental analysis, conductivity measurement, IR and electronic spectral studies. The crystal structure of the complex has been determined by X-ray single-crystal diffraction. The structure consists of crystallized water molecules and neutral two-dimensional copper(II) coordination polymeric networks constructed both by the bis-tridentate μ-trans-dmapox and tetra-monodentate μ₄-btc bridging ligands. Each btc ligand links four trans-dmapox-bridged binuclear copper(II) building blocks [Cu₂(H₂O)₂(trans-dmapox)]²⁺ and each binuclear copper(II) building block attaches to two btc ligands forming an infinite 2D layer which consists of 4+4 grids with dimensions of 13.563(5) × 15.616(5) Å. The environment around the copper(II) atom can be described as a distorted square-pyramid and the Cu?Cu separations through μ-trans-dmapox and μ₄-btc bridging ligands are 5.225 Å (Cu1-Cu1ⁱ), 5.270 Å (Cu2-Cu2ⁱⁱ), 6.115 Å (Cu1-Cu2), 9.047 Å (Cu1-Cu2ⁱⁱⁱ) and 10.968 Å (Cu1-Cu1ⁱⁱⁱ), respectively. Abundant hydrogen bonds among the crystallized, the coordinated water molecules, and the uncoordinated carboxyl oxygen atoms cross-link the two-dimensional layers into an overall three-dimensional channel-like framework. The interaction of the copper(II) polymer with calf thymus DNA (CT-DNA) has been investigated by using absorption, emission spectral and electrochemical techniques. The results indicate that the copper(II) polymer interacts with DNA strongly (K_b = 4.8 × 10⁵ M⁻¹ and K_sv = 1.1 × 10⁴) and the interaction mode between the copper(II) polymer and DNA may be the groove binding. To the best of our knowledge, this is the first report about the crystal structure and DNA-binding studies of a two-dimensional copper(II) polymer bridged both by the trans-oxamidate and btc ligands.     

The new helical zigzag chain {[Ag(Pepy)(NO3)]}∞ and mononuclear [HPepy(FeCl4)] with 3D network based on hydrogen bonds as well as π-π interactions

The title complexes, {[Ag(Pepy)(NO₃)]}_∞ (1) and [HPepy(FeCl₄)] (2) (Pepy = trans-2-(2-phenylethyleneyl)pyridine), had been synthesized and characterized structurally by single-crystal X-ray diffraction analysis, FTIR as well as thermal analysis. The geometrical structure of complex 1 is a one-dimensional helical zigzag chain. Each Ag^I center is five-coordinated by two anions and one Pepy ligand while the anion is an uncommon tetra-dentate coordinating to two Ag^I by O atoms, respectively. The anions connecting with Ag^I as bridge blocks resulted in the formation of crystalline of helical polymeric chain. In the mononuclear complex 2, the Fe^III center is four-coordinated by four Cl⁻ as [FeCl₄]⁻ anion, which connected with hydrogen atoms from the protonated N atom and the C atoms from HPepy⁺ to form multivalent hydrogen bonded network through N-H?Cl and C-H?Cl interactions. The two frameworks can be both considered as a 3D structure driven by diverse hydrogen bonds as well as π-π stacking interactions.     

Syntheses and crystal structures of the first iridium complexes with m- and p-terphenyl (tp). {[Ir2(p-tp)(cod)2](BF4)2 · 2CH2Cl2}3 and [Ir(m-tp)(η-C5Me5)](BF4)2

Novel two iridium terphenyl complexes were prepared and their structures were characterized crystallographically. The reaction of [Ir(cod)₂]BF₄ with p-terphenyl (p-tp) in CH₂Cl₂ was carried out to afford dinuclear Ir(I) complex {[Ir₂(p-tp)(cod)₂](BF₄)₂ · 2CH₂Cl₂}₃ (cod=1,5-cyclooctadiene) (1 · 2CH₂Cl₂), whereas the reaction of the intermediate [Ir(η⁵-C₅Me₅)(Me₂CO)₃]³⁺ in Me₂CO with m-terphenyl (m-tp) was done to provide mononuclear Ir(III) complex [Ir(m-tp)(η⁵-C₅Me₅)](BF₄)₂ (2). In complex 1 · 2CH₂Cl₂, two Ir atoms are η⁶-coordinated to both sides of terminal benzene rings from the upper and lower sides in the p-tp ligand, while one Ir atom is η⁶-coordinated to one side of the terminal benzene ring in the m-tp ligand in complex 2. Each crystal structure describes the first coordination mode found in metal complexes with the m- and p-tp ligands.     

Reactions of the pentamethylcyclopentadienyl trisulfido tungsten with M′Cl2 (M′ = Zn, Cd, Hg): Isolation and structural characterization of [PPh4][(η-C5Me5)WS3(ZnCl2)] and [{(η-C5Me5)WS3}2Hg]

Reactions of [PPh₄][(η⁵-C₅Me₅)WS₃] with equimolar M′Cl₂ (M′ = Zn, Cd) in MeCN or 0.5 equiv. of HgCl₂ in DMF afforded two binuclear clusters [PPh₄][(η⁵-C₅Me₅)WS₃(M′Cl₂)] (1: M′ = Zn; 2: M′ = Cd) and one trinuclear cluster [{(η⁵-C₅Me₅)WS₃}₂Hg] (3). Compounds 1-3 were characterized by elemental analysis, IR, UV-Vis, ¹H NMR and X-ray crystallography. Compound 1 may be viewed as a 1:1 composite of [PPh₄][(η⁵-C₅Me₅)WS₃] and ZnCl₂, in which one [(η⁵-C₅Me₅)WS₃]⁻ anion binds a ZnCl₂ moiety via two μ-S atoms. In the structure of 3, two [(η⁵-C₅Me₅)WS₃]⁻ anions coordinate the central Hg atom via two μ-S atoms, forming an unique bent linear structure. In addition, internal redox reactions of [PPh₄][(η⁵-C₅Me₅)WS₃] under the presence of M′Cl₂ (M′ = Zn, Cd, Hg) in high concentrations were discussed.